시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 피부재생용 줄기세포 치료 시장 보고서(2025년)
Skin Regeneration Stem Cell Therapy Global Market Report 2025
상품코드 : 1889577
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,573,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,501,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,429,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

피부재생용 줄기세포 치료 시장 규모는 최근 급속도로 확대되고 있습니다. 2024년 81억 4,000만 달러에서 2025년에는 91억 9,000만 달러에 달하고, CAGR 12.9%로 성장할 것으로 예상되고 있습니다. 지난 수년간의 성장은 만성 상처 증가, 피부 이식 대체 요법에 대한 수요 증가, 재생 의료에 대한 인지도 향상, 화상 환자 증가, 의료비 지출 증가 등의 요인과 관련이 있습니다.

피부재생용 줄기세포 치료 시장 규모는 향후 수년간 빠른 성장이 예상됩니다. 2029년에는 147억 5,000만 달러에 달하고, CAGR은 12.5%를 나타낼 전망입니다. 예측기간의 성장은 당뇨병성 발궤양의 유병률 상승, 저침습 치료에 대한 수요 증가, 줄기세포 연구 프로그램의 확충, 임상시험의 성공률 향상, 의료 인프라에 대한 투자 증가에 의해 견인될 것으로 전망됩니다. 예측기간의 주요 동향으로는 줄기세포 배양기술의 진보, 조직공학의 혁신, 바이오엔지니어링에 의한 피부대체재의 개발, 연구개발투자 증가, 세포 기반 전달 시스템의 진전을 들 수 있습니다.

재생 의료에 대한 관심 증가는 피부재생용 줄기세포 치료 시장의 성장을 이끌 것으로 예측됩니다. 재생 의료는 손상된 세포, 조직, 장기를 복구, 대체, 재생하여 정상 기능을 회복시키는 것을 목적으로 하는 과학 분야입니다. 만성질환과 변성질환의 증가에 따라 이 분야에 대한 주목이 높아지고 있습니다. 재생 의료 접근법은 증상 관리를 넘어 손상된 조직의 회복과 장기적인 치유를 제공할 가능성을 갖고 있기 때문입니다. 피부재생용 줄기세포 치료는 손상 또는 노화된 피부를 복구 및 젊어지게 하는 세포 기반 치료를 진전시킴으로써 이 동향을 뒷받침하고 있습니다. 예를 들어, 2025년 11월 미국 식품의약국(FDA)은 2023 회계연도에 35건의 재생의료선진요법(RMAT) 지정 신청을 접수했습니다. 이는 2022 회계연도의 30건에서 증가하였으며, 이 분야에서의 연구활동의 활성화를 반영하고 있습니다.

피부재생용 줄기세포 치료 시장의 기업은 손상 모방 처리를 한 간엽계 줄기세포를 활용하여 재생 효과를 높이는 노력을 강화하고 있습니다. 이 줄기세포는 손상을 전제로 전처리되어 재생 인자의 분비 촉진, 콜라겐 합성의 촉진, 피부 복구의 가속화를 도모합니다. 예를 들어, 2025년 1월에는 미국에 본사를 둔 재생 피부과학 기업인 Robles BioCeutics LLC사가 줄기세포를 원료로 하는 화장품 'Glowselle'을 출시했습니다. 이 제품은 콜라겐 생성을 촉진하고 피부 투과성 처방을 통해 재생 인자를 공급하고 손상 모방 처리를 실시한 중간엽 줄기세포를 채용함으로써 최적화된 재생 효과를 실현하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장의 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Skin regeneration stem cell therapy is a regenerative medicine technique that uses stem cells to repair, restore, or rejuvenate damaged skin tissue, promoting healing, reducing scarring, and improving the skin's structure, function, or appearance. This therapy leverages the ability of stem cells to differentiate into various skin cell types and release growth factors and cytokines that accelerate skin regeneration, making it suitable for treating wounds, burns, ulcers, scars, and age-related skin conditions.

The key types of skin regeneration stem cell therapy include autologous and allogeneic stem cell treatments. Autologous therapies use a patient's own stem cells. The different cell sources include adipose-derived stem cells, bone marrow-derived stem cells, and umbilical cord-derived stem cells. Key applications include burn treatment, chronic wound healing, cosmetic surgery, and skin rejuvenation, and the therapies are used by various end users such as hospitals, cosmetic clinics, and research laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The skin regeneration stem cell therapy market research report is one of a series of new reports from The Business Research Company that provides skin regeneration stem cell therapy market statistics, including the skin regeneration stem cell therapy industry global market size, regional shares, competitors with the skin regeneration stem cell therapy market share, detailed skin regeneration stem cell therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the skin regeneration stem cell therapy industry. This skin regeneration stem cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The skin regeneration stem cell therapy market size has grown rapidly in recent years. It will grow from $8.14 billion in 2024 to $9.19 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be linked to increasing prevalence of chronic wounds, rising demand for skin graft alternatives, growing awareness of regenerative medicine, increasing number of burn injuries, and rising healthcare expenditure.

The skin regeneration stem cell therapy market size is expected to see rapid growth in the next few years. It will grow to $14.75 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be driven by rising prevalence of diabetic foot ulcers, growing demand for minimally invasive treatments, expansion of stem cell research programs, increasing clinical trial success rates, and growing investment in healthcare infrastructure. Major trends in the forecast period include technological advancements in stem cell culture, innovations in tissue engineering, development of bioengineered skin substitutes, increased investment in research and development, and advancements in cell-based delivery systems.

The rising focus on regenerative medicine is expected to drive the growth of the skin regeneration stem cell therapy market. Regenerative medicine is a scientific field dedicated to repairing, replacing, or regenerating damaged cells, tissues, or organs to restore normal function. This focus is increasing due to the growing prevalence of chronic and degenerative diseases, as regenerative approaches offer the potential to restore damaged tissues and provide long-term healing beyond symptom management. Skin regeneration stem cell therapy supports this trend by advancing cell-based treatments that repair and rejuvenate damaged or aging skin. For example, in November 2025, the U.S. Food and Drug Administration (FDA) recorded 35 regenerative medicine advanced therapy (RMAT) designation requests in fiscal year 2023, up from 30 requests in fiscal year 2022, reflecting rising activity in the field.

Companies in the skin regeneration stem cell therapy market are increasingly leveraging injury-mimetic treated mesenchymal stem cells to enhance regenerative outcomes. These stem cells are preconditioned under simulated injury conditions to boost the secretion of regenerative factors, promote collagen synthesis, and accelerate skin repair. For instance, in January 2025, Robles BioCeutics LLC, a U.S.-based regenerative dermatology company, launched Glowselle-a stem cell-powered cosmetic product that enhances collagen production, delivers regenerative factors through skin-permeable formulations, and employs injury-mimetic treated mesenchymal stem cells for optimized regenerative effects.

In May 2025, AOP Health, an Austria-based healthcare technology company, partnered with RHEACELL GmbH & Co. KG to develop therapies for epidermolysis bullosa (commonly known as "butterfly children's disease") and chronic venous ulcers. The collaboration combines AOP Health's commercialization expertise with RHEACELL's advanced stem cell research to deliver innovative treatments for severe, inflammation-driven skin diseases. RHEACELL is a Germany-based, late-stage, fully integrated biopharmaceutical company specializing in stem cell therapies for high unmet medical needs in skin regeneration.

Major companies operating in the skin regeneration stem cell therapy market are KenCare Holdings Pte Ltd, Vericel Corporation, AVITA Medical Inc., Celularity Inc., StemRIM Inc., Stem Health Plus Ltd., Castle Creek Biosciences, Cutiss AG, Bioscience Institute S.p.A., Acorn Biomedical Inc., RepliCel Life Sciences Inc., Anterogen Co. Ltd., Cynata Therapeutics Limited, TOPs Cells Co. Ltd., STEM CELLS CARE (INDIA) PRIVATE LIMITED, R3 Stem Cell LLC., Lipogems International S.p.A., PolarityTE Inc., CellReg Aesthetics GmbH, MITAKY High-Tech Corporation.

North America was the largest region in the skin regeneration stem cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in skin regeneration stem cell therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the skin regeneration stem cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The skin regeneration stem cell therapy market consists of revenues earned by entities by providing services such as stem cell isolation and processing services, cryopreservation and storage services, clinical therapy services, research and development services, regulatory and quality assurance services, and post-treatment monitoring and follow-up care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The skin regeneration stem cell therapy market also includes sales of stem cell-based skin grafts and patches, regenerative skin creams and serums, cell therapy kits, regenerative scaffolding systems, and bioactive wound gels. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Skin Regeneration Stem Cell Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on skin regeneration stem cell therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for skin regeneration stem cell therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The skin regeneration stem cell therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Skin Regeneration Stem Cell Therapy Market Characteristics

3. Skin Regeneration Stem Cell Therapy Market Trends And Strategies

4. Skin Regeneration Stem Cell Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Skin Regeneration Stem Cell Therapy Growth Analysis And Strategic Analysis Framework

6. Skin Regeneration Stem Cell Therapy Market Segmentation

7. Skin Regeneration Stem Cell Therapy Market Regional And Country Analysis

8. Asia-Pacific Skin Regeneration Stem Cell Therapy Market

9. China Skin Regeneration Stem Cell Therapy Market

10. India Skin Regeneration Stem Cell Therapy Market

11. Japan Skin Regeneration Stem Cell Therapy Market

12. Australia Skin Regeneration Stem Cell Therapy Market

13. Indonesia Skin Regeneration Stem Cell Therapy Market

14. South Korea Skin Regeneration Stem Cell Therapy Market

15. Western Europe Skin Regeneration Stem Cell Therapy Market

16. UK Skin Regeneration Stem Cell Therapy Market

17. Germany Skin Regeneration Stem Cell Therapy Market

18. France Skin Regeneration Stem Cell Therapy Market

19. Italy Skin Regeneration Stem Cell Therapy Market

20. Spain Skin Regeneration Stem Cell Therapy Market

21. Eastern Europe Skin Regeneration Stem Cell Therapy Market

22. Russia Skin Regeneration Stem Cell Therapy Market

23. North America Skin Regeneration Stem Cell Therapy Market

24. USA Skin Regeneration Stem Cell Therapy Market

25. Canada Skin Regeneration Stem Cell Therapy Market

26. South America Skin Regeneration Stem Cell Therapy Market

27. Brazil Skin Regeneration Stem Cell Therapy Market

28. Middle East Skin Regeneration Stem Cell Therapy Market

29. Africa Skin Regeneration Stem Cell Therapy Market

30. Skin Regeneration Stem Cell Therapy Market Competitive Landscape And Company Profiles

31. Skin Regeneration Stem Cell Therapy Market Other Major And Innovative Companies

32. Global Skin Regeneration Stem Cell Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Skin Regeneration Stem Cell Therapy Market

34. Recent Developments In The Skin Regeneration Stem Cell Therapy Market

35. Skin Regeneration Stem Cell Therapy Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기